| answer text |
<p>Officials across the Department, the UK Health Security Agency, and NHS England
are continuing to develop options and plans based on the Joint Committee on Vaccination
and Immunisation’s advice, regarding expanded respiratory syncytial virus (RSV) immunisation
programmes to protect infants and older adults.</p><p>This is taking into account
clinical and operational factors, such as timing and coordination with other national
immunisation programmes. As part of this work, the Government is engaging the market
on its requirements for products that would enable RSV programmes to be implemented.
A final decision on these programmes will be taken following the outcome of this process.</p>
|
 |
